Wuhan Hualong Biopharmaceutical

Wuhan Hualong Biopharmaceutical is a China-based pharmaceutical manufacturer focused on research, production, and commercialization of injectable medicines. The company operates from Wuhan, Hubei, and manufactures lyophilized powder injections, large-volume injections, small-volume injections, and active pharmaceutical ingredients including ganciclovir. Public business-directory descriptions indicate strengths in biopharmaceutical peptide products and note a leading domestic position for its polygeline peptide injection product. The company appears to be a fully operating commercial-stage manufacturer rather than a venture-stage clinical biotech, with activity centered on marketed hospital injectables and manufacturing expansion projects.